nyse:gsk
|
https://www.indeed.com/cmp/glaxosmithkline
|
Aug 29th, 2022 12:00AM
|
Open
|
GSK
|
|
Healthcare
|
GSK is a global biopharma company with a special purpose – to unite science, technology and talent to get ahead of disease together – so we can positively impact the health of billions of people and deliver stronger, more sustainable shareholder returns – as an organisation where people can thrive. Getting ahead means preventing disease as well as treating it, and we aim to impact the health of 2.5 billion people around the world in the next 10 years.
|
RRv1_OVER_10B
|
Brentford, London
|
Emma Walmsley
|
|
|
4.10
|
73.0
|
71.0
|
74.0
|
74.0
|
67.0
|
68.0
|
65.0
|
73.0
|
64.0
|
69.0
|
68.0
|
73.0
|
72.0
|
530.0
|
4803
|
4800
|
3.90
|
4.10
|
3.60
|
3.70
|
4.00
|
263.00
|
About two weeks
|
291.00
|
MEDIUM
|
304.00
|
FAVORABLE
|
|
|
|
Aug 29th, 2022 01:34PM
|
Aug 29th, 2022 01:34PM
|
GlaxoSmithKline
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nyse:gsk
|
https://www.indeed.com/cmp/glaxosmithkline
|
Aug 28th, 2022 12:00AM
|
Open
|
GSK
|
|
Healthcare
|
We are uniting science, technology and talent to get ahead of disease together.
We are a science-led global healthcare company. We have 3 global businesses that research, develop and manufacture innovative pharmaceutical medicines, vaccines and consumer healthcare products.
We aim to bring differentiated, high-quality and needed healthcare products to as many people as possible, with our 3 global businesses, scientific and technical know-how and talented people.
We also have a significant global presence with commercial operations in more than 150 countries, a network of 64 manufacturing sites in 31 countries and large R&D facilities in the UK, USA, Spain, Belgium and China.
We know that healthy communities depend on healthy people, and healthy communities are the backbone of strong, sustainable societies. As a business, we have responsibilities to society, and society has expectations of us. Our goal is to meet those responsibilities and expectations – and, where possible, exceed them.
|
RRv1_OVER_10B
|
Brentford, London
|
Emma Walmsley
|
|
|
4.10
|
73.0
|
71.0
|
74.0
|
74.0
|
67.0
|
68.0
|
65.0
|
73.0
|
64.0
|
69.0
|
68.0
|
73.0
|
72.0
|
530.0
|
4802
|
4800
|
3.90
|
4.10
|
3.60
|
3.70
|
4.00
|
263.00
|
About two weeks
|
291.00
|
MEDIUM
|
304.00
|
FAVORABLE
|
|
|
|
Aug 28th, 2022 06:53AM
|
Aug 28th, 2022 06:53AM
|
GlaxoSmithKline
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nyse:gsk
|
https://www.indeed.com/cmp/glaxosmithkline
|
Aug 27th, 2022 12:00AM
|
Open
|
GSK
|
|
Healthcare
|
We are uniting science, technology and talent to get ahead of disease together.
We are a science-led global healthcare company. We have 3 global businesses that research, develop and manufacture innovative pharmaceutical medicines, vaccines and consumer healthcare products.
We aim to bring differentiated, high-quality and needed healthcare products to as many people as possible, with our 3 global businesses, scientific and technical know-how and talented people.
We also have a significant global presence with commercial operations in more than 150 countries, a network of 64 manufacturing sites in 31 countries and large R&D facilities in the UK, USA, Spain, Belgium and China.
We know that healthy communities depend on healthy people, and healthy communities are the backbone of strong, sustainable societies. As a business, we have responsibilities to society, and society has expectations of us. Our goal is to meet those responsibilities and expectations – and, where possible, exceed them.
|
RRv1_OVER_10B
|
Brentford, London
|
Emma Walmsley
|
|
|
4.10
|
73.0
|
71.0
|
74.0
|
74.0
|
67.0
|
68.0
|
65.0
|
73.0
|
64.0
|
69.0
|
68.0
|
73.0
|
72.0
|
530.0
|
4802
|
4800
|
3.90
|
4.10
|
3.60
|
3.70
|
4.00
|
263.00
|
About two weeks
|
291.00
|
MEDIUM
|
304.00
|
FAVORABLE
|
|
|
|
Aug 27th, 2022 05:55AM
|
Aug 27th, 2022 05:55AM
|
GlaxoSmithKline
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nyse:gsk
|
https://www.indeed.com/cmp/glaxosmithkline
|
Aug 25th, 2022 12:00AM
|
Open
|
GSK
|
|
Healthcare
|
We are uniting science, technology and talent to get ahead of disease together.
We are a science-led global healthcare company. We have 3 global businesses that research, develop and manufacture innovative pharmaceutical medicines, vaccines and consumer healthcare products.
We aim to bring differentiated, high-quality and needed healthcare products to as many people as possible, with our 3 global businesses, scientific and technical know-how and talented people.
We also have a significant global presence with commercial operations in more than 150 countries, a network of 64 manufacturing sites in 31 countries and large R&D facilities in the UK, USA, Spain, Belgium and China.
We know that healthy communities depend on healthy people, and healthy communities are the backbone of strong, sustainable societies. As a business, we have responsibilities to society, and society has expectations of us. Our goal is to meet those responsibilities and expectations – and, where possible, exceed them.
|
RRv1_OVER_10B
|
Brentford, London
|
Emma Walmsley
|
|
|
4.10
|
73.0
|
71.0
|
74.0
|
74.0
|
67.0
|
68.0
|
65.0
|
73.0
|
64.0
|
69.0
|
68.0
|
73.0
|
72.0
|
530.0
|
4797
|
4800
|
3.90
|
4.10
|
3.60
|
3.70
|
4.00
|
263.00
|
About two weeks
|
291.00
|
MEDIUM
|
304.00
|
FAVORABLE
|
|
|
|
Aug 25th, 2022 10:32AM
|
Aug 25th, 2022 10:32AM
|
GlaxoSmithKline
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nyse:gsk
|
https://www.indeed.com/cmp/glaxosmithkline
|
Aug 23rd, 2022 12:00AM
|
Open
|
GSK
|
|
Healthcare
|
We are uniting science, technology and talent to get ahead of disease together.
We are a science-led global healthcare company. We have 3 global businesses that research, develop and manufacture innovative pharmaceutical medicines, vaccines and consumer healthcare products.
We aim to bring differentiated, high-quality and needed healthcare products to as many people as possible, with our 3 global businesses, scientific and technical know-how and talented people.
We also have a significant global presence with commercial operations in more than 150 countries, a network of 64 manufacturing sites in 31 countries and large R&D facilities in the UK, USA, Spain, Belgium and China.
We know that healthy communities depend on healthy people, and healthy communities are the backbone of strong, sustainable societies. As a business, we have responsibilities to society, and society has expectations of us. Our goal is to meet those responsibilities and expectations – and, where possible, exceed them.
|
RRv1_OVER_10B
|
Brentford, London
|
Emma Walmsley
|
|
|
4.10
|
73.0
|
71.0
|
74.0
|
74.0
|
67.0
|
68.0
|
65.0
|
73.0
|
64.0
|
69.0
|
68.0
|
73.0
|
72.0
|
530.0
|
4797
|
4800
|
3.90
|
4.10
|
3.60
|
3.70
|
4.00
|
263.00
|
About two weeks
|
291.00
|
MEDIUM
|
304.00
|
FAVORABLE
|
|
|
|
Aug 23rd, 2022 12:24PM
|
Aug 23rd, 2022 12:24PM
|
GlaxoSmithKline
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nyse:gsk
|
https://www.indeed.com/cmp/glaxosmithkline
|
Aug 21st, 2022 12:00AM
|
Open
|
GSK
|
|
Healthcare
|
We are uniting science, technology and talent to get ahead of disease together.
We are a science-led global healthcare company. We have 3 global businesses that research, develop and manufacture innovative pharmaceutical medicines, vaccines and consumer healthcare products.
We aim to bring differentiated, high-quality and needed healthcare products to as many people as possible, with our 3 global businesses, scientific and technical know-how and talented people.
We also have a significant global presence with commercial operations in more than 150 countries, a network of 64 manufacturing sites in 31 countries and large R&D facilities in the UK, USA, Spain, Belgium and China.
We know that healthy communities depend on healthy people, and healthy communities are the backbone of strong, sustainable societies. As a business, we have responsibilities to society, and society has expectations of us. Our goal is to meet those responsibilities and expectations – and, where possible, exceed them.
|
RRv1_OVER_10B
|
Brentford, London
|
Emma Walmsley
|
|
|
4.10
|
73.0
|
71.0
|
74.0
|
74.0
|
67.0
|
68.0
|
65.0
|
73.0
|
64.0
|
69.0
|
68.0
|
73.0
|
72.0
|
530.0
|
4797
|
4800
|
3.90
|
4.10
|
3.60
|
3.70
|
4.00
|
263.00
|
About two weeks
|
291.00
|
MEDIUM
|
304.00
|
FAVORABLE
|
|
|
|
Aug 21st, 2022 02:10PM
|
Aug 21st, 2022 02:10PM
|
GlaxoSmithKline
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nyse:gsk
|
https://www.indeed.com/cmp/glaxosmithkline
|
Aug 20th, 2022 12:00AM
|
Open
|
GSK
|
|
Healthcare
|
We are uniting science, technology and talent to get ahead of disease together.
We are a science-led global healthcare company. We have 3 global businesses that research, develop and manufacture innovative pharmaceutical medicines, vaccines and consumer healthcare products.
We aim to bring differentiated, high-quality and needed healthcare products to as many people as possible, with our 3 global businesses, scientific and technical know-how and talented people.
We also have a significant global presence with commercial operations in more than 150 countries, a network of 64 manufacturing sites in 31 countries and large R&D facilities in the UK, USA, Spain, Belgium and China.
We know that healthy communities depend on healthy people, and healthy communities are the backbone of strong, sustainable societies. As a business, we have responsibilities to society, and society has expectations of us. Our goal is to meet those responsibilities and expectations – and, where possible, exceed them.
|
RRv1_OVER_10B
|
Brentford, London
|
Emma Walmsley
|
|
|
4.10
|
73.0
|
71.0
|
74.0
|
74.0
|
67.0
|
68.0
|
65.0
|
73.0
|
64.0
|
69.0
|
68.0
|
73.0
|
72.0
|
530.0
|
4797
|
4800
|
3.90
|
4.10
|
3.60
|
3.70
|
4.00
|
262.00
|
About two weeks
|
289.00
|
MEDIUM
|
304.00
|
FAVORABLE
|
|
|
|
Aug 20th, 2022 03:49PM
|
Aug 20th, 2022 03:49PM
|
GlaxoSmithKline
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nyse:gsk
|
https://www.indeed.com/cmp/glaxosmithkline
|
Aug 19th, 2022 12:00AM
|
Open
|
GSK
|
|
Healthcare
|
We are uniting science, technology and talent to get ahead of disease together.
We are a science-led global healthcare company. We have 3 global businesses that research, develop and manufacture innovative pharmaceutical medicines, vaccines and consumer healthcare products.
We aim to bring differentiated, high-quality and needed healthcare products to as many people as possible, with our 3 global businesses, scientific and technical know-how and talented people.
We also have a significant global presence with commercial operations in more than 150 countries, a network of 64 manufacturing sites in 31 countries and large R&D facilities in the UK, USA, Spain, Belgium and China.
We know that healthy communities depend on healthy people, and healthy communities are the backbone of strong, sustainable societies. As a business, we have responsibilities to society, and society has expectations of us. Our goal is to meet those responsibilities and expectations – and, where possible, exceed them.
|
RRv1_OVER_10B
|
Brentford, London
|
Emma Walmsley
|
|
|
4.10
|
73.0
|
71.0
|
74.0
|
74.0
|
67.0
|
68.0
|
65.0
|
73.0
|
64.0
|
69.0
|
68.0
|
73.0
|
72.0
|
530.0
|
4797
|
4800
|
3.90
|
4.10
|
3.60
|
3.70
|
4.00
|
262.00
|
About two weeks
|
289.00
|
MEDIUM
|
304.00
|
FAVORABLE
|
|
|
|
Aug 19th, 2022 02:09PM
|
Aug 19th, 2022 02:09PM
|
GlaxoSmithKline
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nyse:gsk
|
https://www.indeed.com/cmp/glaxosmithkline
|
Aug 18th, 2022 12:00AM
|
Open
|
GSK
|
|
Healthcare
|
We are uniting science, technology and talent to get ahead of disease together.
We are a science-led global healthcare company. We have 3 global businesses that research, develop and manufacture innovative pharmaceutical medicines, vaccines and consumer healthcare products.
We aim to bring differentiated, high-quality and needed healthcare products to as many people as possible, with our 3 global businesses, scientific and technical know-how and talented people.
We also have a significant global presence with commercial operations in more than 150 countries, a network of 64 manufacturing sites in 31 countries and large R&D facilities in the UK, USA, Spain, Belgium and China.
We know that healthy communities depend on healthy people, and healthy communities are the backbone of strong, sustainable societies. As a business, we have responsibilities to society, and society has expectations of us. Our goal is to meet those responsibilities and expectations – and, where possible, exceed them.
|
RRv1_OVER_10B
|
Brentford, London
|
Emma Walmsley
|
|
|
4.10
|
73.0
|
71.0
|
74.0
|
74.0
|
67.0
|
68.0
|
65.0
|
73.0
|
64.0
|
69.0
|
68.0
|
73.0
|
72.0
|
530.0
|
4797
|
4800
|
3.90
|
4.10
|
3.60
|
3.70
|
4.00
|
262.00
|
About two weeks
|
289.00
|
MEDIUM
|
304.00
|
FAVORABLE
|
|
|
|
Aug 18th, 2022 06:27AM
|
Aug 18th, 2022 06:27AM
|
GlaxoSmithKline
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nyse:gsk
|
https://www.indeed.com/cmp/glaxosmithkline
|
Aug 17th, 2022 12:00AM
|
Open
|
GSK
|
|
Healthcare
|
We are uniting science, technology and talent to get ahead of disease together.
We are a science-led global healthcare company. We have 3 global businesses that research, develop and manufacture innovative pharmaceutical medicines, vaccines and consumer healthcare products.
We aim to bring differentiated, high-quality and needed healthcare products to as many people as possible, with our 3 global businesses, scientific and technical know-how and talented people.
We also have a significant global presence with commercial operations in more than 150 countries, a network of 64 manufacturing sites in 31 countries and large R&D facilities in the UK, USA, Spain, Belgium and China.
We know that healthy communities depend on healthy people, and healthy communities are the backbone of strong, sustainable societies. As a business, we have responsibilities to society, and society has expectations of us. Our goal is to meet those responsibilities and expectations – and, where possible, exceed them.
|
RRv1_OVER_10B
|
Brentford, London
|
Emma Walmsley
|
|
|
4.10
|
73.0
|
71.0
|
74.0
|
74.0
|
67.0
|
68.0
|
65.0
|
73.0
|
64.0
|
69.0
|
68.0
|
73.0
|
72.0
|
529.0
|
4796
|
4800
|
3.90
|
4.10
|
3.60
|
3.70
|
4.00
|
262.00
|
About two weeks
|
289.00
|
MEDIUM
|
304.00
|
FAVORABLE
|
|
|
|
Aug 17th, 2022 11:31AM
|
Aug 17th, 2022 11:31AM
|
GlaxoSmithKline
|
Health Care
|
Pharmaceuticals & Biotechnology
|